Is Routine 39-Week Induction of Labor in Healthy Pregnancy a Reasonable Course?
A Roundtable Discussion
This supplement is sponsored by Ferring Pharmaceuticals.
April 10, 2019|ObGyn
In this supplement to OBG Management a panel of experts discuss the risks and benefits of routine induction of labor (IOL) at 39 weeks. The panelists examine the findings from the ARRIVE trial and the potential impact on real-world practice. The experts also describe their own approach to IOL at 39 weeks and what they see for the future.
,Panelists
- Errol R. Norwitz, MD, PhD, MBA (Moderator)
- Aaron B. Caughey, MD, PhD
- John T. Repke, MD
- Sindhu K. Srinivas, MD, MSCE